As it relates to cervical cancer, NCAM1 downregulation has been shown to be associated with carcinoma in situ of the cervix in comparison to its levels in women with HPV infections in the absence of dysplasia [51]. The gene discussed is NCAM1; the disease is uterine cervix carcinoma in situ.